国金证券 (600109.SH) Latest Company News

Sep 4, 2026, 10:57 UTC
Shanghai Haihe Pharmaceutical R&D Co., Ltd.'s STAR Market IPO review status changed to 'Under Inquiry', with Guojin Securities as the sponsor.
Source:
- finance.sina.cn
Sep 4, 2026, 09:08 UTC
Guojin Securities' continuous supervision period for Shenzeruitai's acquisition of a 26.54% stake in Honghui Fruit and Vegetable ended on August 21, 2026, terminating its supervisory duties.
Source:
- finance.sina.cn
Aug 23, 2026, 09:51 UTC
Dajin Heavy Industry received research visits from 91 institutions including Sinolink Securities on August 21, 2026, during which management explained that the decline in second-quarter profit compared with the first quarter was mainly due to industry operating characteristics and periodic non-operating factors.
Source:
- wap.eastmoney.com
Aug 13, 2026, 02:11 UTC
Multiple Chinese brokerages announced share repurchase plans and shareholder increases in August 2026, including Changjiang Securities planning to repurchase 100-200 million yuan, Dongwu Securities' controlling shareholder planning to increase holdings by 100-200 million yuan, and Industrial Securities' shareholder planning to increase holdings by 30-60 million yuan.
Source:
Aug 7, 2026, 08:33 UTC
Shareholder Zhang Pinguang of Yutong Optical released a pledge of 6.75 million shares on August 6, 2026, accounting for 11.99% of his holdings and 1.29% of the company's total share capital.
Source:
- finance.sina.cn
Aug 4, 2026, 01:31 UTC
Sainovosheng Technology (Beijing) Co., Ltd. filed for filing guidance registration with the Beijing Securities Regulatory Bureau on August 3, 2026, planning to publicly issue shares to unspecified qualified investors and list on the Beijing Stock Exchange, with Guojin Securities as the guidance broker.
Source:
- finance.sina.cn
Jul 19, 2026, 23:51 UTC
Sinolink Securities announced a share buyback of 150 million to 300 million yuan, and by June 30 had repurchased 10.2508 million shares for 89 million yuan.
Source:
Jul 15, 2026, 11:37 UTC
Sinolink Securities adjusted the repurchase price cap from 13 yuan per share to 12.92 yuan per share due to the implementation of the 2025 profit distribution, effective July 22, 2026.
Source:
- finance.sina.cn

600109.SH

Shanghai Haihe Pharmaceutical R&D Co., Ltd.'s STAR Market IPO review status changed to 'Under Inquiry', with Guojin Securities as the sponsor.

Guojin Securities' continuous supervision period for Shenzeruitai's acquisition of a 26.54% stake in Honghui Fruit and Vegetable ended on August 21, 2026, terminating its supervisory duties.

Shareholder Zhang Pinguang of Yutong Optical released a pledge of 6.75 million shares on August 6, 2026, accounting for 11.99% of his holdings and 1.29% of the company's total share capital.

Sinolink Securities announced a share buyback of 150 million to 300 million yuan, and by June 30 had repurchased 10.2508 million shares for 89 million yuan.

Sinolink Securities adjusted the repurchase price cap from 13 yuan per share to 12.92 yuan per share due to the implementation of the 2025 profit distribution, effective July 22, 2026.